Measurement of mucosal conductivity by MII is a potential marker of mucosal integrity restored in infants on acid-suppression therapy

Journal of Pediatric Gastroenterology and Nutrition

Volumn 53, Issue 1, 2011, Pages 120-123

  Loots, Clara M ^a   Van Wijk, Michiel P ^a   Smits, Marije J ^a   Wenzl, Tobias G ^b   Benninga, Marc A ^a   Omari, Taher I ^c  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

children; dilated intracellular spaces; esomeprazole; impedance; infants; mucosal integrity; pH impedance; proton pump inhibitor; reflux; reflux disease treatment

Indexed keywords

ESOMEPRAZOLE; PROTON PUMP INHIBITOR;

APNEA; ARTICLE; CHILD; COMPUTER ASSISTED IMPEDANCE TOMOGRAPHY; ESOPHAGEAL MULTICHANNEL INTRALUMINAL IMPEDANCE; ESOPHAGUS MUCOSA; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; INFANT; MEMBRANE CONDUCTANCE; MORNING DOSAGE; MUCOSA; PRIORITY JOURNAL; VOMITING;

ANTI-ULCER AGENTS; BIOLOGICAL MARKERS; COHORT STUDIES; ELECTRIC CONDUCTIVITY; ELECTROCHEMICAL TECHNIQUES; ESOPHAGUS; GASTROESOPHAGEAL REFLUX; HUMANS; HYDROGEN-ION CONCENTRATION; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MUCOUS MEMBRANE; OMEPRAZOLE; PROTON PUMP INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 79959854473     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318214c3cc     Document Type: Article

References (25)

1. Silny J. Intraluminal multiple electric impedance procedure for measurement of gastrointestinal motility. J Gastrointest Motil 1991;3:151-62.
2. Del Buono R, Wenzl TG, Rawat D, et al. Acid and nonacid gastrooesophageal reflux in neurologically impaired children: investigation with the multiple intraluminal impedance procedure. J Pediatr Gastroenterol Nutr 2006;43:331-5. (Pubitemid 44368188)
3. Loots CM, Benninga MA, Davidson GP, et al. Addition of pH-impedance monitoring to standard pH monitoring increases the yield of symptom association analysis in infants and children with gastroesophageal reflux. J Pediatr 2009;154:248-52.
4. Rosen R, Lord C, Nurko S. The sensitivity of multichannel intraluminal impedance and the pH probe in the evaluation of gastroesophageal reflux in children. Clin Gastroenterol Hepatol 2006;4:167-72. (Pubitemid 43199686)
5. Rosen R, Nurko S. The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms. Am J Gastroenterol 2004;99:2452-8. (Pubitemid 40039378)
6. van Wijk MP, Benninga MA, Omari TI. Role of the multichannel intraluminal impedance technique in infants and children. J Pediatr Gastroenterol Nutr 2009;48:2-12.
7. Wenzl TG. Evaluation of gastroesophageal reflux events in children using multichannel intraluminal electrical impedance. Am J Med 2003;115(suppl 3A):161S-5S.
8. Wasko-Czopnik D, Blonski W, Paradowski L. Diagnostic difficulties during combined multichannel intraluminal impedance and pH monitoring in patients with esophagitis or Barrett's esophagus. Adv Med Sci 2007;52:196-8.
9. Farré R, Blondeau K, Clement D, et al. Evaluation of esophageal mucosa integrity "in vivo." Validation of basal intraluminal impedance measurements to assess non-erosive changes induced by esophageal acid exposure in rabbit and healthy human subjects. Gastroenterology 2010;138:S555.
10. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a metaanalysis. Gastroenterology 1997;112:1798-810. (Pubitemid 27240763)
11. Khan M, Santana J, Donnellan C, et al. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev 2007;2:CD003244.
12. Savarino V, Di Mario F, Scarpignato C. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety. Pharmacol Res 2009;59:135-53.
13. Moore DJ, Tao BS, Lines DR, et al. Double-blind placebo-controlled trial of omeprazole in irritable infants with gastroesophageal reflux. J Pediatr 2003;143:219-23. (Pubitemid 37082956)
14. Tighe MP, Afzal NA, Bevan A, et al. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. Paediatr Drugs 2009;11:185-202.
15. Tolia V, Bishop PR, Tsou VM, et al. Multicenter, randomized, doubleblind study comparing 10, 20 and 40mg pantoprazole in children (5-11 years) with symptomatic gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2006;42:384-91. (Pubitemid 43841020)
16. Orenstein SR, Hassall E, Furmaga-Jablonska W, et al. Multicenter double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr 2009;154:514-20.
17. Omari TI, Miki K, Fraser R, et al. Esophageal body and lower esophageal sphincter function in healthy premature infants. Gastroenterology 1995;109:1757-64.
18. Omari TI, Lundborg P, Sandstrom M, et al. Pharmacodynamics and systemic exposure of esomeprazole in preterm infants and term neonates with gastroesophageal reflux disease. J Pediatr 2009;155:222-8.
19. van Wijk MP, Sifrim D, Rommel N, et al. Characterisation of intraluminal impedance patterns associated with gas reflux (belching) in healthy volunteers. Gastroenterology 2006;130:A116.
20. Campanozzi A, Boccia G, Pensabene L, et al. Prevalence and natural history of gastroesophageal reflux: pediatric prospective survey. Pediatrics 2009;123:779-83.
21. Gilger MA, El-Serag HB, Gold BD, et al. Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study. J Pediatr Gastroenterol Nutr 2010;47:141-6.
22. Van Malenstein H, Farre? R, Sifrim D. Esophageal dilated intercellular spaces (DIS) and nonerosive reflux disease. Am J Gastroenterol 2008;103:1021-8. (Pubitemid 351501085)
23. Edebo A, Vieth M, Tam W, et al. Circumferential and axial distribution of esophageal mucosal damage in reflux disease. Dis Esophagus 2007;20:232-8. (Pubitemid 46831257)
24. Calabrese C, Bortolotti M, Fabbri A, et al. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol 2005;100:537-42. (Pubitemid 40487549)
25. Farre R, Fornari F, Blondeau K, et al. Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut 2010;59:164-9.